ABL Diagnostics Showcases Scientific Progress at EMHH 2026, Supporting Strategic Positioning in Molecular Technologies
WOIPPY, FRANCE, June 10, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), a specialist in molecular technologies, bioinformatics and decision-support solutions for infectious diseases, announces the presentation of three …